Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Primary Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103232359A details a mild base-catalyzed nitrile hydrolysis method. This technology offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN104447540A offers copper-catalyzed amide synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharma intermediates.
Novel Pd-catalyzed route for aryl primary sulfonamides. High yield, wide substrate scope. Cost-effective manufacturing solution for pharma intermediates.
Patent CN107935878A enables one-pot rhodium-catalyzed carbonylation amidation for primary amides with simplified steps and enhanced supply chain reliability in pharmaceutical manufacturing.
Patent CN107935878A enables atom-economical primary amide synthesis from olefins CO and ammonia This one-pot method ensures high yield stable catalyst performance reducing manufacturing costs enhancing supply chain reliability for pharmaceutical intermediates
Discover how metal-free amide synthesis reduces production costs and safety risks for pharmaceutical intermediates. Scale-ready, high-yield process with 99% purity. Contact us for custom synthesis solutions.